CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

Right arrow Help viewing high resolution images
Right arrow Return to article
Click on image to view larger version.



Fig. 7. Cells expressing farnesylated RhoA are still sensitive to growth inhibition by inhibition of GGTaseI. Cultures of NIH 3T3 cells stably expressing RhoA(63L)-WT or RhoA(63L)-CVLS were incubated with growth medium supplemented with 3 or 10 µM GGTI-2166. Cell number was determined on days 3, 5, 6, 8, 10, and 12, with data shown for day 12, are the average of duplicate dishes and are representative of three independent experiments; bars, SE.





Right arrow Return to article


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation